136 related articles for article (PubMed ID: 9290699)
1. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM
Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
[TBL] [Abstract][Full Text] [Related]
2. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
[TBL] [Abstract][Full Text] [Related]
3. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
5. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors.
Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM
Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence.
Sarabia SF; Liehr JG
Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
Walker C; Ahn YT; Everitt J; Yuan X
Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
[TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors.
Shiao YH; Rice JM; Anderson LM; Diwan BA; Hard GC
J Natl Cancer Inst; 1998 Nov; 90(22):1720-3. PubMed ID: 9827526
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumors.
Shiao YH; Kamata SI; Li LM; Hooth MJ; DeAngelo AB; Anderson LM; Wolf DC
Cancer Lett; 2002 Dec; 187(1-2):207-14. PubMed ID: 12359370
[TBL] [Abstract][Full Text] [Related]
12. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
Zhuang Z; Roth MJ; Emmert-Buck MR; Lubensky IA; Liotta LA; Solomon D
Acta Cytol; 1994; 38(5):671-5. PubMed ID: 8091895
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma gene mutation in primary human renal cell carcinoma.
Shuin T; Torigoe S; Kubota Y; Kishida T; Hosaka M; Horikoshi T; Yao M; Kondo K; Sakai N; Danenberg K
Oncol Res; 1995; 7(2):63-6. PubMed ID: 7579728
[TBL] [Abstract][Full Text] [Related]
14. Establishment of experimental conditions for the rapid detection of mutations in the von Hippel-Lindau gene by parallel temperature gradient gel electrophoresis.
Hernández A; Meyer A; Enczmann J; Ackermann R; Wernet P
Electrophoresis; 1999 Jul; 20(10):1958-61. PubMed ID: 10451103
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors.
Shiao YH; Ramakrishna G; Anderson LM; Perantoni AO; Rice JM; Diwan BA
Cancer Lett; 2002 May; 179(1):33-8. PubMed ID: 11880179
[TBL] [Abstract][Full Text] [Related]
16. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
[TBL] [Abstract][Full Text] [Related]
17. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
[TBL] [Abstract][Full Text] [Related]
19. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
20. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
